Bayer Raises Guidance on Pharma Division Performance
Story updates
06:36:31 AM UTC
SquawkNews
Bayer Had Seen Pharma Division 2026 Adjusted Ebitda Margin at 23%-25%
06:58:08 AM UTC
SquawkNews
German pharmaceuticals and agriculture group Bayer XETR:BAYN on Tuesday raised its 2026 profit outlook, citing a better-than-anticipated performance at the company's pharmaceuticals business.The company now expects adjusted core earnings, on a currency-adjusted basis, to reach between €9.8-10.3 bil…